清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Combination finerenone and empagliflozin for chronic kidney disease with type 2 diabetes: a target trial emulation

医学 恩帕吉菲 置信区间 肾脏疾病 倾向得分匹配 蛋白尿 内科学 危险系数 审查(临床试验) 观察研究 荟萃分析 2型糖尿病 糖尿病 血液透析 2型糖尿病 临床试验 随机对照试验 比例危险模型 造影剂肾病 急性肾损伤 相对风险 高钾血症
作者
Lei Li,Dan Zhang,Manrong Xu,Shaohua Li,Yun Shen,Shengdi Lu
出处
期刊:Frontiers in nephrology [Frontiers Media]
卷期号:6: 1930977-1930977
标识
DOI:10.3389/fneph.2026.1930977
摘要

Objective: This study aims to emulate the CONFIDENCE trial and compare combination finerenone plus empagliflozin with each monotherapy for albuminuria reduction in Chinese patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Design: This study employed modified target trial emulation. The primary contrast was the per-protocol effect, estimated by cloning, censoring, and inverse probability of censoring weighting, which is not susceptible to grace-period immortal time bias; a propensity-score-matched assignment analysis, the observational analogue of intention-to-treat, was secondary. Setting: Electronic health records from three Chinese tertiary (Grade A) hospitals, from January 2023 to September 2025, were utilized. Participants: A total of 2,895 adults (965 per strategy) with CKD and T2D met the CONFIDENCE eligibility criteria, selected by 1:1:1 propensity score matching from 3,822 eligible patients. Main outcome measures: Relative change in urine albumin-to-creatinine ratio (UACR) from baseline to day 180 was the main outcome measure (co-primary comparisons with Holm-Bonferroni correction). Results: < 0.001); this is not a true intention-to-treat effect and is supportive only. Hyperkalemia occurred in 12.7%, 12.8%, and 3.5%, respectively, acute kidney injury in 4.9%, 2.8%, and 2.3%, respectively, and symptomatic hypotension in 1.9%, 0.6%, and 0.4%, respectively. The findings were consistent across 10 sensitivity analyses and six subgroups. Conclusions: Combination finerenone and empagliflozin was associated with greater albuminuria reduction than either monotherapy, directionally consistent with CONFIDENCE. Because the emulated strategy permitted sequential initiation within 90 days whereas CONFIDENCE randomized simultaneous initiation, this is a modified emulation rather than a direct replication. Albuminuria is a surrogate endpoint and follow-up was 180 days, so hard kidney and cardiovascular outcomes remain unstudied. Despite loss to follow-up of 29.6% to 32.7%, the finding was robust in a tipping-point analysis. Hyperkalemia was frequent with finerenone, so biochemical monitoring remains necessary. Findings apply to comparable Chinese tertiary-care populations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
solger发布了新的文献求助10
1秒前
坚定的问芙完成签到,获得积分10
2秒前
虚心从蓉完成签到,获得积分10
3秒前
李健的小迷弟的应助被气945采纳,获得10
11秒前
16秒前
漂亮的幻枫完成签到,获得积分10
19秒前
朱洪帆发布了新的文献求助10
22秒前
27秒前
369ninja发布了新的文献求助10
30秒前
威武妙柏完成签到,获得积分10
30秒前
气945完成签到,获得积分20
31秒前
气945驳回了李健的应助
37秒前
Shiyuzz完成签到 ,获得积分10
42秒前
gzhy完成签到,获得积分10
47秒前
丰富广缘完成签到,获得积分10
49秒前
美好傲蕾完成签到,获得积分10
51秒前
hj完成签到 ,获得积分10
52秒前
温暖友易完成签到,获得积分10
54秒前
mycn完成签到,获得积分10
56秒前
58秒前
求求了给篇文献完成签到,获得积分10
58秒前
陈微完成签到,获得积分10
59秒前
怕孤独的亚男完成签到,获得积分10
59秒前
慢波完成签到,获得积分10
1分钟前
cloudy完成签到,获得积分10
1分钟前
顺利毛豆完成签到,获得积分10
1分钟前
苏苏完成签到,获得积分10
1分钟前
1分钟前
愤怒的衬衫完成签到,获得积分10
1分钟前
腼腆的冰安完成签到,获得积分10
1分钟前
不一样的烟火完成签到,获得积分10
1分钟前
烂漫的慕卉完成签到,获得积分10
1分钟前
无情捕完成签到,获得积分10
1分钟前
沐雨汐完成签到,获得积分10
1分钟前
朱洪帆发布了新的文献求助10
1分钟前
科研绿老头完成签到,获得积分10
1分钟前
WULAVIVA完成签到,获得积分10
1分钟前
1分钟前
踏实远山完成签到,获得积分10
1分钟前
剑剑完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166414
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750507
捐赠科研通 7757221
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553489
邀请新用户注册赠送积分活动 2473845